ProMetic’s technologies are used to remove pathogens from blood, and extract and recover valuable proteins
from plasma.
ProMetic develops therapeutics to treat blood-related disorders and is a world-leading technology provider and drug developer in the fields of hematology, oncology and nephrology.
FIRST QUARTER 2012 FINANCIAL RESULTS CONFERENCE CALL (MAY 15, 2012 10:00AM)
Audio link
FIRST QUARTER 2012 PRESENTATION
